Yu Chi Yang

Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling

Eric G. Bluemn, Ilsa M. Coleman, Jared M. Lucas et al. · Cancer Cell · 2017 · 733 citations · Full text

Urology, Hormonal Receptor, Fibroblast Growth Factor +4

Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor

Raymond J. Andersen, Nasrin R. Mawji, Jun Wang et al. · Cancer Cell · 2010 · 504 citations · Full text

Androgen Receptor, Urology, Endocrine-related Cancer +8

Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown et al. · Journal of Clinical Investigation · 2019 · 439 citations · Full text

Scnpc Pdx Models, Urology, Stratifies Diverse Phenotypes +15

An androgen receptor N-terminal domain antagonist for treating prostate cancer

Jae-Kyung Myung, Carmen A. Bañuelos, Javier Fernández et al. · Journal of Clinical Investigation · 2013 · 307 citations · Full text

Androgen Receptor, Molecular Biology, Pharmacotherapy +16

Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.

Kabirullah Lutfy, Shoshana Eitan, Camron D. Bryant et al. · PubMed · 2003 · 220 citations

Pain Medicine, Molecular Pain, Orl-1 Receptor Antagonist +19